Clinical Trials
2 trialsNCT01582009 2022-08-15
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
Roswell Park Cancer Institute
Phase 1/2 Terminated
NCT00900276 2018-07-05
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
Wake Forest University Health Sciences
Completed